American Lung Association and the American Thoracic Society Response to Philip Morris International’s Purchase of British Producer of Respiratory Treatments

This post was originally published on this site

In response to an announcement from Philip Morris International that the company has agreed to acquire Vectura, a British inhaled medicine company, American Lung Association President and CEO Harold Wimmer and American Thoracic Society President Lynn Schnapp MD, ATSF shared the following statement: